(BHC) Bausch Health - Performance -8.1% in 12m
BHC performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-63.26%
#136 in Peer-Group
Rel. Strength
29.91%
#5395 in Stock-Universe
Total Return 12m
-8.09%
#107 in Peer-Group
Total Return 5y
-61.02%
#115 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 1.76 |
| High / Low | USD |
|---|---|
| 52 Week High | 9.78 USD |
| 52 Week Low | 4.32 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 79.97 |
| Buy/Sell Signal +-5 | -1.94 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: BHC (-8.1%) vs XLV (-4.8%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-3.42% | 131% | 313% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
3.1% | 16.7% | 81% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
0.51% | -14.7% | 405% | 63.7 | 35.8 | 1.2 | 58.2% | 18.9% |
| NOVN SW Novartis |
0.14% | 4.1% | 53.5% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-5.82% | 3.79% | 51.6% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-8.26% | -8.24% | 110% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| AZN NASDAQ AstraZeneca |
-4.1% | -7.38% | 46.1% | 27.9 | 15.4 | 0.93 | 72.4% | 45.1% |
| UCB BR UCB |
5.98% | 19.9% | 66.1% | 31.1 | 22 | 1.04 | -22.4% | 39.5% |
Performance Comparison: BHC vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for BHC
| Total Return (including Dividends) | BHC | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 37.86% | 1.09% | 3.75% |
| 3 Months | 39.29% | 1.98% | 25.32% |
| 12 Months | -8.09% | -4.84% | 13.11% |
| 5 Years | -61.02% | 45.05% | 109.78% |
| Trend Score (consistency of price movement) | BHC | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 97.2% | 20.4% | 80.3% |
| 3 Months | 53.8% | -22.1% | 97.2% |
| 12 Months | -43% | -76.5% | 45.4% |
| 5 Years | -74.7% | 87.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th95.50 | 36.37% | 32.87% |
| 3 Month | %th72.00 | 36.59% | 11.15% |
| 12 Month | %th46.50 | -3.42% | -18.75% |
| 5 Years | %th41.50 | -73.13% | -81.42% |
FAQs
Does Bausch Health (BHC) outperform the market?
No,
over the last 12 months BHC made -8.09%, while its related Sector, the Health Care Sector SPDR (XLV) made -4.84%.
Over the last 3 months BHC made 39.29%, while XLV made 1.98%.
Performance Comparison BHC vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
BHC vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.8% | 34.1% | -20.3% | -21% |
| US NASDAQ 100 | QQQ | -2.3% | 33.7% | -21.9% | -20% |
| German DAX 40 | DAX | -3.6% | 37.7% | -33.1% | -38% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -2.9% | 34.1% | -24% | -30% |
| Hongkong Hang Seng | HSI | -1.3% | 34.8% | -40.8% | -47% |
| India NIFTY 50 | INDA | -1.1% | 37.1% | -20.9% | -7% |
| Brasil Bovespa | EWZ | -1.1% | 32% | -42.3% | -16% |
BHC vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -0.4% | 34.4% | -24.8% | -32% |
| Consumer Discretionary | XLY | -1.1% | 35.9% | -12.5% | -24% |
| Consumer Staples | XLP | -0.6% | 37.5% | -20.8% | -16% |
| Energy | XLE | -4.9% | 31.1% | -16.6% | -10% |
| Financial | XLF | -0.5% | 35.1% | -22.9% | -36% |
| Health Care | XLV | -0.1% | 36.8% | -11.4% | -3% |
| Industrial | XLI | -1.9% | 34.7% | -27.2% | -33% |
| Materials | XLB | -2.6% | 34.1% | -23.9% | -14% |
| Real Estate | XLRE | -0.7% | 38% | -19.2% | -20% |
| Technology | XLK | -3.5% | 30.7% | -24.4% | -18% |
| Utilities | XLU | -0.4% | 36.6% | -22.7% | -30% |
| Aerospace & Defense | XAR | -2.5% | 34.1% | -38.5% | -56% |
| Biotech | XBI | -3.3% | 37.3% | -6.2% | 1% |
| Homebuilder | XHB | -0.5% | 31.9% | -12.4% | -11% |
| Retail | XRT | -1.9% | 36.3% | -15.6% | -18% |
BHC vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -5.4% | 31.1% | -14.0% | -4% |
| Natural Gas | UNG | 0.5% | 48.3% | -1.1% | -2% |
| Gold | GLD | -0.2% | 38.7% | -38.1% | -47% |
| Silver | SLV | -3% | 38.2% | -35.9% | -26% |
| Copper | CPER | -8.3% | 27.8% | -40.7% | -26% |
BHC vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 1.1% | 36.8% | -16.6% | -5% |
| iShares High Yield Corp. Bond | HYG | -1.1% | 36.6% | -18.7% | -18% |